United States Government Publishing Office publisher pbl distributor dst United States Congress Senate author aut Government Organization text government publication eng BILLS To prevent conflicts of interest that stem from the revolving door that raises concerns about the independence of pharmaceutical regulators.;Pharmaceutical Regulation Conflict of Interest Act;S. 2057 (IS) Bills and Statutes 115_cong_bills legislative 2017-11-06 U.S. Government Publishing Office 2017-11-01 monographic deposited born digital 17 p. Y 1.6: Y 1.4/1: P0b002ee1976af783 https://www.govinfo.gov/app/details/BILLS-115s2057is S. 2057 021-610-00252-9 000501532 000325576 Congressional bills Senate bills f:s2057_is.txt https://www.govinfo.gov/app/details/BILLS-115s2057is https://www.govinfo.gov/content/pkg/BILLS-115s2057is/html/BILLS-115s2057is.htm https://www.govinfo.gov/content/pkg/BILLS-115s2057is/pdf/BILLS-115s2057is.pdf https://www.govinfo.gov/content/pkg/BILLS-115s2057is/xml/BILLS-115s2057is.xml fdlp DGPO 2017-11-06 2023-01-04 BILLS-115s2057is machine generated eng Tammy Baldwin United States Senate sponsor spn United States Congress Member Dianne Feinstein United States Senate cosponsor United States Congress Member Kamala D. Harris United States Senate cosponsor United States Congress Member Margaret Wood Hassan United States Senate cosponsor United States Congress Member Edward J. Markey United States Senate cosponsor United States Congress Member Jeanne Shaheen United States Senate cosponsor United States Congress Member Tom Udall United States Senate cosponsor United States Congress Member United States Congress Senate Committee on Homeland Security and Governmental Affairs associated name asn Title 2 Section 1602 Title 2 Section 4702(a) 2 U.S.C. 1602 2 U.S.C. 4702(a) Title 18 Section 207 18 U.S.C. 207 Title 19 Section 2171(b)(4) 19 U.S.C. 2171(b)(4) Title 21 Section 321 21 U.S.C. 321 Title 25 Section 450i(j) Title 25 Section 5304 Title 25 Section 5323(j) 25 U.S.C. 450i(j) 25 U.S.C. 5304 25 U.S.C. 5323(j) Title 42 Section 2297h-3(c) Title 42 Section 262 42 U.S.C. 2297h-3(c) 42 U.S.C. 262 Title 49 Section 106(p)(6)(I)(ii) 49 U.S.C. 106(p)(6)(I)(ii) s BILLS-115s2057is 115 1 SENATE SENATE 2057 is is Pharmaceutical Regulation Conflict of Interest Act To prevent conflicts of interest that stem from the revolving door that raises concerns about the independence of pharmaceutical regulators. Ms. Baldwin (for herself, Mrs. Feinstein, Ms. Harris, Ms. Hassan, Mr. Markey, Mrs. Shaheen, and Mr. Udall) introduced the following bill; which was read twice and referred to the Committee on Homeland Security and Governmental Affairs Committee on Homeland Security and Governmental Affairs Homeland Security and Governmental Affairs Ms. Baldwin Tammy Baldwin Baldwin, Tammy Mrs. Feinstein Dianne Feinstein Feinstein, Dianne Ms. Harris Kamala D. Harris Harris, Kamala D. Ms. Kamala Harris Ms. Hassan Margaret Wood Hassan Hassan, Margaret Wood Ms. Maggie Hassan Mr. Markey Edward J. Markey Markey, Edward J. Mr. Edward Markey Mrs. Shaheen Jeanne Shaheen Shaheen, Jeanne Mr. Udall Tom Udall Udall, Tom false false